Anna Pfeffer

580 total citations
24 papers, 471 citations indexed

About

Anna Pfeffer is a scholar working on Physiology, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Anna Pfeffer has authored 24 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 10 papers in Psychiatry and Mental health and 5 papers in Molecular Biology. Recurrent topics in Anna Pfeffer's work include Alzheimer's disease research and treatments (11 papers), Dementia and Cognitive Impairment Research (10 papers) and Folate and B Vitamins Research (3 papers). Anna Pfeffer is often cited by papers focused on Alzheimer's disease research and treatments (11 papers), Dementia and Cognitive Impairment Research (10 papers) and Folate and B Vitamins Research (3 papers). Anna Pfeffer collaborates with scholars based in Poland, Sweden and Germany. Anna Pfeffer's co-authors include Maria Barcikowska, Marek Gołębiowski, Małgorzata Gaweł, Maria Styczyńska, Dorota Religa, E Łuczywek, B. Wasiak, Tomasz Gabryelewicz, Barbara Steiner and Beata Pepłońska and has published in prestigious journals such as Scientific Reports, Experimental Neurology and Behavioural Brain Research.

In The Last Decade

Anna Pfeffer

24 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Pfeffer Poland 11 238 134 101 100 61 24 471
Barbara Schaffer United States 7 298 1.3× 157 1.2× 196 1.9× 140 1.4× 73 1.2× 9 590
Isabel Hernández Spain 12 251 1.1× 130 1.0× 177 1.8× 57 0.6× 32 0.5× 23 461
Lars-Olof Wahlund Sweden 6 260 1.1× 99 0.7× 223 2.2× 217 2.2× 48 0.8× 7 540
Xuewen Xiao China 13 205 0.9× 211 1.6× 79 0.8× 61 0.6× 46 0.8× 41 546
Diane Jansen Netherlands 13 264 1.1× 88 0.7× 45 0.4× 79 0.8× 94 1.5× 16 490
Wanda Łojkowska Poland 12 183 0.8× 125 0.9× 90 0.9× 33 0.3× 36 0.6× 19 479
Riya Thomas United States 10 269 1.1× 188 1.4× 66 0.7× 28 0.3× 63 1.0× 16 636
Shi-Jie Liu United States 11 218 0.9× 217 1.6× 68 0.7× 26 0.3× 166 2.7× 11 587
Lorraine Hamelin France 6 368 1.5× 131 1.0× 123 1.2× 61 0.6× 74 1.2× 12 622
Xiaoping Xu China 11 190 0.8× 163 1.2× 58 0.6× 206 2.1× 91 1.5× 20 534

Countries citing papers authored by Anna Pfeffer

Since Specialization
Citations

This map shows the geographic impact of Anna Pfeffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Pfeffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Pfeffer more than expected).

Fields of papers citing papers by Anna Pfeffer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Pfeffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Pfeffer. The network helps show where Anna Pfeffer may publish in the future.

Co-authorship network of co-authors of Anna Pfeffer

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Pfeffer. A scholar is included among the top collaborators of Anna Pfeffer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Pfeffer. Anna Pfeffer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klein, Charlotte, et al.. (2022). Transposon‐mediated glial cell line‐derived neurotrophic factor overexpression in human adipose tissue‐derived mesenchymal stromal cells: A potential approach for neuroregenerative medicine?. Journal of Tissue Engineering and Regenerative Medicine. 16(6). 515–529. 1 indexed citations
2.
Klein, Charlotte, et al.. (2020). Chia seeds as a potential cognitive booster in the APP23 Alzheimer’s disease model. Scientific Reports. 10(1). 18215–18215. 9 indexed citations
3.
4.
Pfeffer, Anna, Jing Guo, Jürgen Braun, et al.. (2017). MR elastography detection of early viscoelastic response of the murine hippocampus to amyloid β accumulation and neuronal cell loss due to Alzheimer's disease. Journal of Magnetic Resonance Imaging. 47(1). 105–114. 62 indexed citations
5.
Barczak, Anna, Tomasz Gabryelewicz, B. Wasiak, et al.. (2013). Clinical Dementia Rating Scale (CDR) and dementia risk in the Mild Cognitive Impairment patients. Postępy Nauk Medycznych. 1 indexed citations
6.
Golańska, Ewa, Anna Pfeffer, Małgorzata Chodakowska-Żebrowska, et al.. (2013). APBB2 genetic polymorphisms are associated with severe cognitive impairment in centenarians. Experimental Gerontology. 48(4). 391–394. 12 indexed citations
7.
Golańska, Ewa, Elizabeth H. Corder, Anna Pfeffer, et al.. (2013). The prion protein M129V polymorphism. Prion. 7(3). 244–247. 6 indexed citations
8.
Barczak, Anna, Tomasz Gabryelewicz, Maciej P. Golan, et al.. (2013). Clinical Dementia Rating Scale (CDR) and dementia risk in the Mild Cognitive Impairment patients** Skala Klinicznej Oceny Stopnia Otępienia (CDR) a ryzyko otępienia u osób z łagodnymi zaburzeniami poznawczymi. 1 indexed citations
9.
Pfeffer, Anna, K Czyźewski, E Łuczywek, et al.. (2011). The Prevalence of Dementia in Warsaw Centenarians: a Population – Based Study**. Postępy Nauk Medycznych. 3 indexed citations
10.
Gabryelewicz, Tomasz, Jolanta Miśko, Jarosław B. Ćwikła, et al.. (2007). Prediction of deterioration of mild cognitive impairment with CT and SPECT.. PubMed. 13 Suppl 1. 31–7. 4 indexed citations
11.
Golańska, Ewa, Piotr Rieske, Maria Styczyńska, et al.. (2005). CYP46: A risk factor for Alzheimer's disease or a coincidence?. Neuroscience Letters. 383(1-2). 105–108. 19 indexed citations
12.
Pfeffer, Anna. (2004). Choroba Alzheimera – obraz kliniczny, rozpoznawanie, możliwości terapeutyczne zaburzeń poznawczych. Przewodnik Lekarza/Guide for GPs. 7(5). 70–78. 2 indexed citations
13.
Żekanowski, Cezary, Beata Pepłońska, Maria Styczyńska, et al.. (2004). The E318G substitution in PSEN1 gene is not connected with Alzheimer's disease in a large Polish cohort. Neuroscience Letters. 357(3). 167–170. 11 indexed citations
14.
Styczyńska, Maria, Dorota Religa, Anna Pfeffer, et al.. (2003). Simultaneous analysis of five genetic risk factors in Polish patients with Alzheimer's disease. Neuroscience Letters. 344(2). 99–102. 39 indexed citations
15.
Żekanowski, Cezary, Maria Styczyńska, Beata Pepłońska, et al.. (2003). Mutations in presenilin 1, presenilin 2 and amyloid precursor protein genes in patients with early-onset Alzheimer's disease in Poland. Experimental Neurology. 184(2). 991–996. 74 indexed citations
16.
Pepłońska, Beata, Cezary Żekanowski, Dorota Religa, et al.. (2003). Strong association between Saitohin gene polymorphism and tau haplotype in the Polish population. Neuroscience Letters. 348(3). 163–166. 22 indexed citations
17.
Łuczywek, E, Anna Nowicka, Anna Pfeffer, et al.. (2002). Cognitive Deficits and Polymorphism of Apolipoprotein E in Alzheimer’s Disease. Dementia and Geriatric Cognitive Disorders. 13(3). 171–177. 8 indexed citations
18.
Gaweł, Małgorzata, et al.. (2001). The Diagnostic Value of EEG in Alzheimer Disease. Journal of Clinical Neurophysiology. 18(6). 570–575. 82 indexed citations
19.
Gołębiowski, Marek, Maria Barcikowska, & Anna Pfeffer. (1999). Magnetic Resonance Imaging-Based Hippocampal Volumetry in Patients with Dementia of the Alzheimer Type. Dementia and Geriatric Cognitive Disorders. 10(4). 284–288. 51 indexed citations
20.
Łałowski, Maciej, K Czyźewski, Anna Pfeffer, Maria Barcikowska, & Hubert Kwieciński. (1998). ApoE polymorphism in Polish patients with Alzheimer's disease. Acta Neurobiologiae Experimentalis. 58(1). 65–68. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barbara Schaffer Breakdown of academic impact, for papers by Isabel Hernández Breakdown of academic impact, for papers by Lars-Olof Wahlund Breakdown of academic impact, for papers by Xuewen Xiao Breakdown of academic impact, for papers by Diane Jansen Breakdown of academic impact, for papers by Wanda Łojkowska Breakdown of academic impact, for papers by Riya Thomas Breakdown of academic impact, for papers by Shi-Jie Liu Breakdown of academic impact, for papers by Lorraine Hamelin Breakdown of academic impact, for papers by Xiaoping Xu
Rankless by CCL
2026